Alan, a SaaS startup for the private health insurance market in France, raises €50M Series C led by Temasek, bringing its total raised to €125M
French startup Alan has raised a $54.4 million (€50 million) Series C funding round. Temasek is leading the round with existing investors …
Context & Ripple Effects
This Temasek-led Series C is the third step on a funding ladder that related coverage traces in full: Alan had raised a $28M Series A in April 2018 and then a $45M Series B in February 2019, so the €50M brings its total to €125M while pulling in a Singaporean state investor as lead.
What makes the round worth revisiting is where that ladder ends up — the same company later sells a healthcare super app to 155K members across France, Belgium and Spain, adds mental health programs in a €183M Series E, and by mid-2026 closes a €480M Prosus round at a €5.5B valuation with €1B+ ARR in sight.
First-order effects
- Alan gains a €125M war chest and a sovereign-wealth anchor investor, giving it runway to push beyond its French private health insurance base into new markets and products.
- Temasek's lead marks a shift in who funds Alan — from European venture capital to global institutional capital validating the model.
Second-order effects
- Incumbent French private health insurers now face a digitally-native competitor with both software economics and deep pockets, pressuring them to match Alan's app-first member experience.
- Successive mega-rounds — Coatue's €185M in 2021, the €183M Series E, Belfius' €173M in 2024 — let Alan bundle adjacent services like mental health into the same platform, widening the gap over rivals that sell insurance alone.
Third-order effects
- If the pattern holds, European insurtech consolidates around full-stack digital carriers rather than SaaS middleware: Alan's own arc runs from 'SaaS platform for insurance' in 2019 to a €5.5B-valued insurer with bank investors like Belfius on the cap table.
- State-backed capital (Temasek here, Belgian banking money later) becoming a recurring feature of European health-tech funding points to national champions being financed across borders as strategic assets.
The trend: European digital health insurers are compounding through ever-larger cross-border rounds, evolving from SaaS platforms into full-stack national champions with sovereign and banking capital behind them.